Barbara Staehelin

Barbara Staehelin was appointed to the Board as Senior Non-Executive Director in July 2021.

Barbara is Non-Executive Chair for Resistell AG and femtech pioneer Ava AG. She is a board member at Assura Group, a Swiss medical insurance company where she is President of the Audit and Risk Committee. She is also co-founder and Chair at Axicos AG.

Barbara Staehelin began her professional career in management consultancy, focussing on healthcare at McKinsey and Co., Inc. She has also served as a member of the Global Executive Committee at F. Hoffman-LaRoche Diagnostics. Her wide experience both in senior leadership roles and in founding companies has given her extensive high-level exposure to commercial, regulatory, and governance matters in the biotech sector.